The global In Vitro Diagnostics (IVD) and Point-of-Care Testing (POCT) market size was valued at USD 89.7 billion in 2022 and is projected to reach USD 155.2 billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030. The rise in demand for early disease detection, personalized medicine, and increasing prevalence of chronic diseases such as diabetes and cardiovascular conditions are driving market growth. The shift towards decentralized healthcare and increasing adoption of home-based testing solutions also contribute to the expansion of the IVD and POCT market. Innovations in diagnostic technologies, along with advancements in molecular diagnostics and automated testing systems, are expected to further fuel the market's growth during the forecast period.
POCT, a key segment of the broader IVD market, is gaining significant traction due to its ability to deliver rapid and accurate results in various healthcare settings. This market is projected to witness substantial growth, with increasing investments in R&D and the development of novel testing devices for conditions like COVID-19, infectious diseases, and metabolic disorders. The global market for POCT alone is expected to reach USD 37.4 billion by 2030, growing at a CAGR of 8.1% from 2024 to 2030. This expansion is attributed to the growing demand for real-time, bedside diagnostics, and the convenience of self-testing solutions for patients and healthcare providers alike.
Download Full PDF Sample Copy of Market Report @
IVD and POCT Market Research Sample Report
The clinics segment in the IVD (In Vitro Diagnostics) and POCT (Point-of-Care Testing) market is experiencing significant growth as diagnostic technologies continue to evolve. Clinics serve as primary healthcare settings where patients receive immediate medical attention and diagnostic services. The demand for IVD and POCT products in clinics has increased due to the growing need for fast, accurate, and cost-effective diagnostic tools for a variety of conditions. IVD products enable healthcare providers to diagnose diseases early, while POCT devices allow for quick results, leading to better patient outcomes and more efficient treatment plans. Additionally, the growing trend of preventive care and regular health check-ups has expanded the market for diagnostic tools in this segment.The POCT market in clinics is particularly prominent, as it allows for on-site testing, thereby reducing the waiting time for lab results and improving overall patient care. Innovations in portable diagnostic devices have made it easier for clinics to implement a wide range of diagnostic tests without the need for extensive lab infrastructure. Furthermore, increased awareness of chronic disease management, especially in outpatient settings, has driven the adoption of IVD and POCT products in clinics. As healthcare providers seek ways to provide fast, personalized care, the market for IVD and POCT technologies in clinics is expected to continue its upward trajectory, offering numerous opportunities for growth in the coming years.
The hospitals segment is one of the largest contributors to the global IVD and POCT market, driven by the growing need for diagnostic solutions in complex medical settings. Hospitals often handle a wide range of medical cases, from emergency treatments to specialized care, which increases the demand for advanced diagnostic equipment. The role of IVD technologies in hospitals is critical for accurate disease diagnosis, patient monitoring, and treatment planning, while POCT devices offer the advantage of real-time results, allowing for immediate clinical decisions. The increasing prevalence of chronic diseases, along with the need for quick decision-making in emergency care, further boosts the adoption of IVD and POCT solutions in hospitals.In recent years, hospitals have embraced the integration of digital health technologies and point-of-care solutions, which is transforming patient care. The use of POCT devices in hospitals allows for faster patient throughput and more efficient resource management, particularly in high-pressure environments like emergency departments and intensive care units. With the increasing demand for personalized medicine and the need for continuous monitoring of patients, hospitals are increasingly turning to IVD and POCT products for better diagnosis, prognosis, and treatment. The market in hospitals is expected to grow as healthcare systems prioritize improving patient outcomes and reducing healthcare costs, thus fostering a robust demand for advanced diagnostic technologies.
The laboratories segment remains a dominant player in the global IVD and POCT market, as clinical laboratories are essential in the accurate diagnosis and monitoring of various diseases. Laboratories offer the infrastructure necessary for conducting a wide range of in vitro diagnostic tests, from routine screenings to specialized tests. IVD technologies, including reagents, assays, and instruments, are integral in laboratory settings, enabling accurate and reliable results that are crucial for patient diagnosis. Laboratories continue to rely on advanced diagnostic tools to keep up with the increasing complexity of disease testing, as well as the rising demand for faster, more accurate results.The demand for laboratory-based IVD products has also increased with advancements in molecular diagnostics, genomics, and personalized medicine. Laboratories are increasingly adopting automated systems and high-throughput testing to improve efficiency and reduce human error. Additionally, while laboratories traditionally offer a controlled environment for diagnostic tests, there is growing interest in integrating POCT solutions that provide fast results at the point of care, which may lead to hybrid models combining laboratory and point-of-care technologies. As the healthcare industry embraces innovation, laboratories are expected to continue leading the adoption of cutting-edge diagnostic technologies that offer enhanced precision, reliability, and speed.
The "Others" segment in the IVD and POCT market encompasses a wide range of end-use applications outside the traditional healthcare settings of clinics, hospitals, and laboratories. This includes diagnostic products used in home care, remote patient monitoring, research facilities, and public health sectors. For instance, home care diagnostics are becoming more popular as patients and caregivers demand at-home testing solutions for chronic disease management, such as glucose monitoring for diabetes. POCT devices in these settings allow individuals to perform tests without the need to visit healthcare facilities, providing convenience and autonomy. This segment is expected to grow rapidly as consumers increasingly seek solutions that fit their lifestyle and healthcare needs.In addition to home care, other significant applications include research and pharmaceutical testing, where IVD and POCT technologies are used for experimental diagnostics and clinical trials. Additionally, public health organizations and governmental agencies are deploying diagnostic tools for large-scale testing in response to health crises, such as infectious disease outbreaks. The growing focus on health monitoring in non-traditional healthcare settings, coupled with the rise in health-conscious consumers, presents significant growth opportunities in this segment. The "Others" category represents a diverse array of applications that are increasingly important in the global IVD and POCT market, with promising prospects for expansion as technology becomes more accessible and consumer-oriented.
For More Information or Query, Visit @ IVD and POCT Market Size And Forecast 2025-2030